Unbeatable Prices
Discreet Fast Shipping on all orders
US Sourced Guaranteed Authentic
100s of Brands
Federal Notice — Docket HHS-OASH-2026-0232
FEDERAL BAN
COMING SOON
On July 6, 2026, HHS opened a 30-day public comment period on a DEA proposal to place 7-hydroxymitragynine (7-OH) into Schedule I. It’s a proposal — not a final decision — and the window to act is now.
Same day shipping & banned state options
10+ years providing excellence to customers
Highly competitive bulk pricing across the board
Timeline
What’s actually on the table
Jul 6
HHS publishes the RFI
The DEA’s Notice of Intent proposes moving 7-OH into Schedule I. This opens a public comment window — it isn’t an immediate ban.
Now
Proposed threshold: ~1mg/serving
At roughly 0.050% 7-OH, the proposed cap would place the large majority of current products — including ours — into Schedule I.
Jul 21
Comment period closes
After this date, the window to influence the outcome narrows. A 2016 comment effort (100,000+ submissions) led the DEA to withdraw a similar proposal.
Why it matters
What this means for consumers
01
Reported real-world use
Many consumers describe using 7-OH and kratom for pain management, wellness routines, and as an alternative to substances with higher risk profiles.
02
A threshold this low functions as a ban
At ~1mg per serving, most products on today’s market — regulated and lab-tested — would no longer be legally available.
03
Regulation vs. prohibition
Advocates are asking for thresholds that reflect real consumer use, arguing prohibition pushes markets underground rather than ending demand.
Shop
Current inventory,
while it’s still legal to sell
Capsules
Drinks
Powder
Extract Shots
Tablets
Vapes
While Inventory Lasts
Browse the Full 7-OH & Kratom Catalog
Comment Period
The comment period is still open
Consumers can still submit public comments on Docket HHS-OASH-2026-0232 through July 31, 2026, before any final threshold is set.